The current prevalence of infectious diseases in many developing regions of the world is a
serious burden, impacting both the general health as well as economic growth of these …

Mucosal surfaces represent important routes of entry into the human body for the majority of
pathogens, and they constitute unique sites for targeted vaccine delivery. Nanoparticle …

Mucosal sites serve as the main portal for the entry of pathogens and thus immunization
through mucosal routes can greatly improve the immunity. Researchers are continuously …

The specialized field of research in vaccination is experiencing potential advances. The
majority of the currently used vaccines are administered by parenteral route. This route …

Mucosal tissue constitutes the largest interface between the body and the external
environment, regulating the entry of pathogens, particles, and molecules. Mucosal …

Over the past several years, immunization and treatment of infectious diseases has
undergone a paradigm shift. Stemming from the vaccine research and development, not …

Although polymeric nanoparticles/microparticles are well established for the mucosal
administration of conventional drugs, they have not yet been developed commercially for …

Mucosal administration especially via the nasal route is a novel and promising technique for
medication and vaccine delivery. Mucosal pathways provide notable benefits that promote …

Most infectious diseases are caused by pathogenic infiltrations from the mucosal tract.
Therefore, vaccines delivered to the mucosal tissues can mimic natural infections and …

Mucosal surfaces are the first site of infection for most infectious diseases and oral
vaccination can provide protection as the first line of defense. Unlike systemic …